Fully automated, ultra-high-volume line providing sub-second cycle time, medical-grade precision, and scalable capacity ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Investing.com -- Glucotrack Inc. (NASDAQ:GCTK) stock surged 60% Thursday after the company announced that the U.S. Patent and ...
Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, ...
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued three patents for its continuous blood glucose monitoring platform as the company moves toward ...
[28 January 2026]: Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a ...
Stressed brain cells can survive longer by slowing sugar use, revealing a short-term protective response that later turns ...
Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization ...
Researchers have developed a new type of porous microneedle that can extract interstitial fluid from skin faster than ever before, without drawing ...
Discover how space research has revolutionized healthcare on Earth, enhancing diagnostics, wearables, and medical ...
Stocktwits on MSN
Why did Glucotrack stock surge 12% pre-market today?
Following the update, Glucotrack stock traded over 12% higher in Thursday’s premarket. New Patents Strengthen IP The US ...
When it comes to powering aircraft, jet engines need dense, energy-packed fuels. Right now, nearly all of that fuel comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results